Labcorp To Spin Off Clinical Development Business
- Wednesday, August 3, 2022, 4:04
- Market
- Add a comment
LH, $257.94; Market Capitalization: $23.3 billion), a leading global life sciences company, announced that its Board of Directors authorized a plan to spin-off Clinical Development business into an independent, publicly traded company.
About the Author
admin123 has written 23412 stories on this site.
